Executive at Dorman Products (DORM) receives 1,725 restricted stock units

Rhea-AI Filing Summary

Dorman Products, Inc. reported that Kathleen Pacheco, President of Specialty Vehicle, received an equity grant tied to company stock. She was awarded 1,725 shares of common stock at a reference price of $115.93 per share as a grant or award, rather than an open-market purchase. After this transaction, her directly held stake increased to 4,784.5305 shares.

The grant is structured as restricted stock units, which convert into shares over time. These units vest in three equal annual installments starting on March 2, 2027, the first anniversary of the grant date, encouraging longer-term alignment with shareholders. The reported total also reflects small additional amounts she acquired earlier through Dorman’s employee stock purchase plan.

Insights

Equity Compensation Analyst

Executive receives time-vested stock units, a routine equity compensation event.

This filing shows Kathleen Pacheco receiving 1,725 restricted stock units that settle in common shares. The reference price is $115.93 per share, indicating the grant’s notional value on the grant date.

The units vest in three equal annual installments beginning on March 2, 2027, promoting multi‑year retention and alignment with shareholders. The filing also notes prior small share purchases through the employee stock purchase plan, which modestly increase her direct ownership.

As this is a standard equity award for a senior executive and not an open‑market trade, it is generally viewed as routine compensation rather than a directional signal about near‑term business performance.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pacheco Kathleen

Role President, Specialty Vehicle

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,725	$115.93	$200K

Holdings After Transaction: Common Stock — 4,784.531 shares (Direct)

Footnotes (1)

1. Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in three equal annual installments beginning on March 2, 2027, which is the first anniversary of the date of grant. The amount reported includes 49.8705 shares acquired by the Reporting Person under Dorman's employee stock purchase plan on June 30, 2025 and 49.6600 shares acquired by the Reporting Person under Dorman's employee stock purchase plan on December 31, 2025.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pacheco Kathleen

(Last) (First) (Middle)

C/O DORMAN PRODUCTS, INC.

3400 EAST WALNUT STREET

(Street)

COLMAR PA 18915

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dorman Products, Inc. [ DORM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Specialty Vehicle

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		A		1,725(1)	A	$115.93	4,784.5305(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in three equal annual installments beginning on March 2, 2027, which is the first anniversary of the date of grant.

2. The amount reported includes 49.8705 shares acquired by the Reporting Person under Dorman's employee stock purchase plan on June 30, 2025 and 49.6600 shares acquired by the Reporting Person under Dorman's employee stock purchase plan on December 31, 2025.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

	/s/ Frank J. Mahr, by Power of Attorney	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Dorman Products (DORM) report for Kathleen Pacheco?

Dorman Products reported that executive Kathleen Pacheco received a grant of 1,725 restricted stock units tied to its common stock. These units represent a contingent right to receive shares over time under a structured vesting schedule beginning March 2, 2027.

Was the DORM insider transaction a stock purchase or a stock grant?

The transaction was a stock grant, not an open-market purchase. Kathleen Pacheco received 1,725 restricted stock units as a grant or award, reflecting equity-based compensation rather than buying shares directly in the market.

How and when do Kathleen Pacheco’s Dorman (DORM) restricted stock units vest?

The restricted stock units vest in three equal annual installments. Vesting begins on March 2, 2027, which is the first anniversary of the grant date, and continues over the following two years, encouraging long-term retention and alignment with shareholder interests.

How many Dorman Products (DORM) shares does Kathleen Pacheco own after this grant?

After this grant, Kathleen Pacheco is reported to beneficially own 4,784.5305 shares of Dorman common stock directly. This total includes the new restricted stock unit award and small amounts previously acquired through the company’s employee stock purchase plan.

What is the reference price for the Dorman (DORM) restricted stock unit grant?

The grant of 1,725 restricted stock units is reported at a reference price of $115.93 per share. This price is used to describe the grant’s notional value on the transaction date and does not necessarily represent a purchase price paid by the executive.

Did Kathleen Pacheco’s prior Dorman (DORM) employee stock purchase plan activity affect this Form 4?

Yes. The filing notes that her total ownership figure includes 49.8705 shares acquired on June 30, 2025 and 49.6600 shares acquired on December 31, 2025 through Dorman’s employee stock purchase plan, in addition to the current restricted stock unit grant.